US FDA approves AstraZeneca’s diabetes drug for treating heart failure risk
The approval by the US Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.